Copyright Notice

• A competing interest is applicable when the professional or personal association with a person or an organization influences the presented information.
• The authors need to declare a conflict of interest, if any, with respect to financial and non-financial (research work) interests.
• If any competing interest exists with any editor or peer reviewer, they are excluded from handling that manuscript to maintain transparency during the editorial and peer-review process.

• This policy has been adopted to publish responsible research findings and to endure that all the necessary approvals and consents have been obtained prior to publication of the outcomes.
• Authors need to testify that their research has been carried out in accordance with the procedure approved by the respective ethics committees of their organizations. The Editor of the journal makes the final decision on the acceptance and rejection of the manuscript subjected to the scrutiny of issues regarding human and animal ethics.
• Clinical research/trials involving human data, human specimens, and human subjects must have been performed in accordance with the Helsinki Declaration of the World Medical Association in 1975, as revised in 2008, concerning Human and Animal Rights under the approval of the ethics committee.
• Justification of the clinical procedure followed may have to be furnished if required by the editor or peer reviewer.
• Authors are expected to secure informed consent for participation in the study by the human subjects.
• The experimental procedure and the outcomes involving animal models must comply with National or International guidelines. The manuscript must include the details (guidelines/permissions/licenses) of such compliance with appropriate references and specifications.

• Scholarly data includes clinical data, quantitative survey observations, statistical algorithms, transcripts, experimental data, images, videos, audio, etc. The data can be in raw or processed form.
• The journal encourages sharing of data associated with the research publications to enhance the chances of accurate reproducibility, better peer review, better funding opportunity, and citations.
• The authors are encouraged to share research data in public data repositories under the open access policy and license terms. Accessibility to the shared data may be indicated in the publications in the form of URLs.
• The data linked to the DOI of the journal enables precise identification and retrieval.

• The publisher applies COPE guidelines for the corrections, retractions, withdrawals, and expression of concerns.
• Errors in publications may necessitate corrections and are given as corrigendum or erratum along with original article citations.
• Concern regarding the conduct or the integrity of the work or fraudulent presentation is generally taken up with the author's sponsoring organization, and the response is conveyed to the Editor-in-Chief for addressing adequately.
• In order to ensure transparency and integrity of the research communications, this policy is implemented.
• An article is subjected to retraction under the following conditions: major technical/scientific/experimental error, unrealistic presentations, data fabrication, redundant publication, plagiarism, inappropriate authorship, or unethical research.
• The editor-in-Chief is the final authority for the retraction of the article. The Editor evaluates the author's response and follows COPE guidelines prior to the retraction.
• The notice of retraction is posted online in the next issue of the journal.
• An article can be withdrawn by the corresponding author prior to the acceptance for publication and not after that or peer-review. Withdrawal is permitted if there is conclusive evidence of a violation of the ethical code, multiple submissions resulting in the redundant publication of the previous publication elsewhere, and authorship claim issues.
• After publication, if the corresponding author, on his behalf or on behalf of all the article authors, requests the withdrawal of the article, a fee of 2.500€ will be charged. Only after payment is verified will the Chief-Editor remove the article from the journal.

• The publisher provides marketing solutions to commercial endeavors to create awareness among the specific targeted audience.
• The commercially sponsored advertisements are absolutely independent of editorial policy and decisions.
• The publisher does not endorse any such advertised products.
• The publisher ensures that the publications are not influenced by commercial interests.
• The discretion for the selection of advertising content remains with the Publisher.
• Retention or withdrawal rights of the online advertisements remain with the Editor or the Publisher.
• Advertisements must comply with National and International advertising regulation guidelines.

ARIS² will support authors by posting the published version of articles for indexation three months after publication.

ARIS² follows a progressive editorial policy that encourages researchers to submit the original research, reviews, and editorial observations as articles, well supported by tables and graphic representation.

All research submitted to ARIS² will comply with "Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)"